LISATA THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lisata Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Lisata Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $225K, a 41.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $225K -$162K -41.9% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $267K -$158K -37.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $308K -$179K -36.8% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $348K -$200K -36.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $387K -$221K -36.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $425K -$242K -36.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $487K -$237K -32.7% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $548K +$226K +70.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $608K +$200K +49% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $667K +$175K +35.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $724K +$150K +26.1% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $322K -$331K -50.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $408K -$323K -44.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $492K -$315K -39% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $574K -$332K -36.6% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $653K -$350K -34.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $731K -$362K -33.1% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $807K -$377K -31.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $906K Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.09M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.18M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.